Меланома и рак кожи

‘Bespoke’ mRNA vaccine significantly reduces risk of melanoma recurrence or death, clinical trial shows

‘Bespoke’ mRNA vaccine significantly reduces risk of melanoma recurrence or death, clinical trial shows The Guardian

Melanoma survivor grateful for personalized cancer vaccine clinical trial

Melanoma survivor grateful for personalized cancer vaccine clinical trial UT MD Anderson

Breakthrough vaccine for the deadliest skin cancer cut risk by almost half

Breakthrough vaccine for the deadliest skin cancer cut risk by almost half The Washington Post

Merck/Moderna cancer vaccine cuts melanoma death or recurrence risk by 42%, shares fall

Merck/Moderna cancer vaccine cuts melanoma death or recurrence risk by 42%, shares fall Reuters

Intismeran Plus Pembrolizumab Reduces Recurrence Risk in Resected Melanoma

Experimental mRNA vaccine cuts risk melanoma returns by 42%

Experimental mRNA vaccine cuts risk melanoma returns by 42% CNN

Study reveals how melanoma outmaneuvers both drugs and immune defenses

Melanoma is one of the most difficult cancers to treat due to its resistance to targeted drug therapies. But a new study from the University of Kentucky Markey Cancer Center shows that the cancer is playing offense as well as defense: In addition to forming resistance against the MAPK inhibitors that are commonly used…

Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report

Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report The New York Times

Detailed data confirm Moderna and Merck cancer vaccine met key endpoints in melanoma trial

Detailed data confirm Moderna and Merck cancer vaccine met key endpoints in melanoma trial STAT

Florida Cancer Specialists & Research Institute Welcomes Kelly Elleson, MD, FACS, Breast and Melanoma Surgical Oncologist

Florida Cancer Specialists & Research Institute Welcomes Kelly Elleson, MD, FACS, Breast and Melanoma Surgical Oncologist PR Newswire

AI device successfully triages skin cancer cases in real-world study

An autonomous AI device was successfully integrated into a real-world health system and managed 94% of urgent suspected skin cancer referrals, according to a presentation at the European Academy of Dermatology and Venerology Congress. The researchers also found that the AI medical device safely discharged over a…

No tumor progression was seen at three-year follow-up in Evaxion's melanoma vaccine trial.

No tumor progression was seen at three-year follow-up in Evaxion's melanoma vaccine trial. Stock Titan

New Findings for Treatment Resistance in Rare Melanoma

New Findings for Treatment Resistance in Rare Melanoma Labroots

After a melanoma diagnosis, mRNA cancer vaccine delivered a patient hope — and a path forward

After a melanoma diagnosis, mRNA cancer vaccine delivered a patient hope — and a path forward STAT

Treatment-related toxicities rare after discharge for TIL therapy

Few patients who receive tumor-infiltrating lymphocyte therapy for advanced melanoma experience serious treatment-related adverse events after discharge. An evaluation of more than 50 individuals who received tumor-infiltrating lymphocyte (TIL) therapy at Memorial Sloan Kettering Cancer Center showed only two…